Seagen

Youtube Subscribe

Open: 228.74 Close: 228.74 Change: 0.0

Our AI found 6 flaws in Seagen Company Inc.

This document will help you to evaluate Seagen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Seagen are: Seagen, Pfizer, acquisition, say, regulatory, close, complete, and the …

Concept Map

Semantic Network

Stock Summary

Seagen Inc. develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors. It has collaboration agreements with Takeda.

Today's Summary

Pfizer-Seagen merger is the largest M&A deal in biopharma since AbbVie acquired Allergan for $63 billion in June 2019. European Commission on Thursday said it found no competitive issues with Pfizers buyout of Seagen. Pfizer plans to conclude the deal on 14 December 2023.

Today's News

Pfizer obtains regulatory approvals for $43bn seagen acquisition. Pfizer plans to conclude the deal on 14 December 2023. The company will create the Pfizer oncology division, merging the oncologist-related commercial activity and the research and development of both companies. Pfizer expects to close $43B Seagen acquisition on Thursday. Pfizer and Seagen have all required regulatory approvals, Pfizer said in a news release that reported a key US antitrust waiting period had expired. European Union cleared the transaction in October, saying the takeover did not raise competition concerns and would not negatively impact prices of treatments. Seagen came to major drugmakers attention with their work on antibodies conjusive unitsフconsjac Patch disgust SalmonHop883 PostV hy CavsOre Seagen Inc. (SGEN) Stock , TAK Stock , Seagen. Takeda Pharmaceuticals. EU Antitrust Regulators Clear Pfizers $43B Acquisition of Seagen. European Commission on Thursday said it found no competitive issues with Pfizers buyout of the antibody-drug conjugate company. Pfizer announced on Tuesday its anticipation to conclude the $43 billion acquisition of cancer drugmaker Seagen later this week. The pharmaceutical giant revealed plans to establish a new cancer division, incorporating Seagen in early 2022024 = SizeAnnaCompareappendounter IbrahimPDFSelect,backs Pfizer-Seagen merger is the largest M&A deal in biopharma since AbbVie acquired Allergan for $63 billion in June 2019. Pfizer expects to close the acquisition of Seagen on December 14, 2023, subject to the satisfaction of other customary closing conditions. Pfizer completed its acquisition of all outstanding common stock of Seagen for $229 in cash per share. European Union cleared the transaction in October, saying the takeover did not raise competition concerns and would not negatively impact prices of treatments. Seagen is a world-leader in antibody-drug conjugates that are designed to preferentially kill cancer cells Pfizer Clears Final Regulatory Hurdles to Acquire Seagen Inc – RamaOnHealthcare. Pfizer expects to close its $43 billion acquisition of Seagen on December 14, 2023. Seagen projects to generate approximately $2.2 billion in revenue in 2023, which is 12% year-over-year growth. Pfizer completes acquisition of Seagen. Pfizer and Seagen have now received all required regulatory approvals, Pfizer said in a news release that reported a key US antitrust waiting period had expired. The big US drugmaker announced the transaction on March 13. Pfizer to close Seagen buyout this week as regulatory reviews complete Dec. 23. Pfizer offered $229 in cash per share to acquire Seagen in March in a deal valued at $43B, including debt. With the addition of Seagen, Pfizers Oncology pipeline has doubled in size. Pfizer completed acquisition of Seagen at $229 in cash per share. Take-Two Interactive Software to be added to Nasdaq-100 Index. Seagen removed due to Pfizer.

Stock Profile

"Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. It offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of adult patients with advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. The company also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-TGT and SEA-CD70 for various cancer diseases. It has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington."

Keywords

How much time have you spent trying to decide whether investing in Seagen? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Seagen are: Seagen, Pfizer, acquisition, say, regulatory, close, complete, and the most common words in the summary are: seagen, pfizer, news, acquisition, stock, cancer, regulatory, . One of the sentences in the summary was: European Commission on Thursday said it found no competitive issues with Pfizers buyout of Seagen. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #seagen #pfizer #news #acquisition #stock #cancer #regulatory.

Read more →

Youtube Subscribe

---